Perrigo Co Plc - Company Profile
Powered by 
All the sales intelligence you need on Perrigo Co Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Perrigo Co Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Perrigo Co Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Perrigo Co Plc (Perrigo) is a pharmaceutical company that develops, manufactures, and markets consumer self-care, over-the-counter health, and wellness solutions. Its products include allergy relief medicines, Infant formulas, cough suppressants, expectorants, sinus medicines, nutritional beverages, antacids, anti-diarrheal, anti-heartburn medicines, sleep-aids, toothbrushes, pain relievers, fever reducers, toothbrush replacement heads, flossers, whitening products, toothbrush covers, smoking cessation and well-being products, feminine hygiene and contraceptives, vitamins, minerals, and supplements, among others. The company offers products to retail drug stores, e-commerce retailers, supermarkets, mass merchandise chains, and major wholesalers in North America, Europe, and Asia. It operates manufacturing facilities in the US, the UK, Belgium, France, Germany, and China. Perrigo is headquartered in Dublin, Ireland.
Headquarters
Ireland
Address
The Sharp Building Hogan Place, Dublin 2, D02TY74
Website
www.perrigo.com
Telephone
353 170 94000
No of Employees
8,100
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
PRGO (NYSE)
Revenue (2024)
$4.3B
-2.8%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-729.7%
(2024 vs 2023)
Market Cap*
$1.5B
Net Profit Margin (2024)
XYZ
-752.7%
(2024 vs 2023)
* As of and is in US$
Perrigo Co Plc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| - | - |
| Cough Suppressants | Compeed |
| Expectorants | Dr. Fresh |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Divestiture | In April, the company sold its branded Dermacosmetics business to Karo Healthcare for EUR332.6 million. |
| 2025 | Contracts/Agreements | In October, Opill partnered with Chillhouse to launch Opill and Chill, promoting accessible, empowering, and stigma-free women's self-care. |
| 2025 | Divestiture | In September, the company sold a portfolio of skin health brands, including ACO, to Karo Healthcare. |
Competitor Comparison
| Key Parameters | Perrigo Co Plc | Johnson & Johnson | The Procter & Gamble Co | Pfizer Inc | Bayer AG |
|---|---|---|---|---|---|
| Headquarters | Ireland | United States of America | United States of America | United States of America | Germany |
| City | Dublin | New Brunswick | Cincinnati | New York City | Leverkusen |
| State/Province | Dublin | New Jersey | Ohio | New York | Nordrhein-Westfalen |
| No. of Employees | 8,100 | 138,200 | 109,000 | 75,000 | 87,757 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Orlando D. Ashford | Chairman | Executive Board | 2022 | 57 |
| Albert A. Manzone | Chief Executive Officer - Interim; Director; President - Interim | Executive Board | 2026 | 62 |
| Eduardo Bezerra | Chief Financial Officer; Executive Vice President | Senior Management | 2022 | 51 |
| Abbie Lennox | Executive Vice President; Chief Scientific Officer | Senior Management | 2025 | 45 |
| Robert Willis | Chief Human Resources Officer; Executive Vice President | Senior Management | 2019 | 57 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer